On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. The ...
Shares of 908 Devices (NASDAQ:MASS) climbed ~71% in the premarket on Tuesday after Repligen (NASDAQ:RGEN) offered $70M in cash to acquire the company’s bioprocessing analytics portfolio. As part of ...
WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN) (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc ...
Repligen purchased 908 Devices’s desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded ...
Portfolio includes PAT devices for real-time process monitoring, control and analysis Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback